Spiriva

What is it?

Composition

The composition of the drug Spiriva is based on the active ingredient tiotropium bromide, which plays a key role in its therapeutic properties. The composition also contains excipients that help ensure the necessary form and facilitate the administration of the drug.

• Tiotropium is the main active ingredient that relaxes the muscles of the respiratory tract, preventing their narrowing.
• The capsule contains additional ingredients that stabilize the main substance and prolong its action.
• The solution itself is presented in a convenient form for inhalation administration, which ensures effective and rapid absorption of the drug directly into the lungs.

The method of administering the intracapsular drug through a special inhaler ensures the accuracy of the dosage and ease of use, which makes the drug easy and safe to use.

How to use?

Using Spiriva requires special attention to dosage and technique to ensure maximum effectiveness of treatment. The drug should be used strictly according to the doctors recommendations, since its dosage and method of administration depend on the condition and characteristics of the patient.

1. The usual dose is 2 inhalations per day, which must be taken at intervals prescribed by the doctor.
2. To use Spiriva HandiHaler, place the capsule with the medicine in the device, close the mouthpiece and press the side button to pierce the capsule.
3. Conduct 2 inhalations to obtain the full dose from one capsule, making sure that the medicine is not swallowed.

It is important to remember that the capsules are intended only for use with the HandiHaler device and should not be taken orally or used with other medical devices.

How does it work?

The principle of action of Spiriva is based on the ability of tiotropium bromide, which is an anticholinergic agent, to block receptors responsible for contraction of the muscles of the airways. This mechanism allows the muscles around the airways to relax, which helps them to expand and improve respiratory function. The drug reduces airway resistance, thereby reducing symptoms such as shortness of breath and wheezing.

The use of the drug allows patients with diseases such as COPD and asthma to tolerate physical activity more easily and reduces the frequency of exacerbations of symptoms. This improves the quality of life of patients suffering from chronic lung diseases and allows them to lead a more active lifestyle without the constant fear of sudden attacks.

Spiriva also provides a long-term effect due to its pharmacological properties, which allows it to be used once a day, providing a stable therapeutic effect for 24 hours. This stability of the drug allows for a reduction in the number of inhalations and maintenance of lung function throughout the day.

Indications

Spiriva is recommended for the treatment of various chronic respiratory diseases in adults and children over 6 years of age. The drug is especially effective for patients suffering from frequent attacks of respiratory failure and bronchospasm.

• Chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, due to the ability to relax muscles and prevent exacerbations of symptoms.
• Asthma in adults and children over 6 years of age, as the drug helps prevent the likelihood of attacks, providing a regular therapeutic effect.
• Patients suffering from frequent bronchospasms, Spiriva helps maintain normal breathing, providing better ventilation of the lungs.

Due to its pharmacological activity, the drug is used in a wide range of patients facing chronic respiratory diseases.

Contraindications

Despite its effectiveness, Spiriva also has contraindications that must be taken into account when prescribing and using the drug. Not all patients can use this medicine safely, and it is important to consult with your doctor about your medical history beforehand.

• You should not use Spiriva if you have an allergy to tiotropium or similar drugs such as ipratropium.
• The drug is not recommended for use in children under 6 years of age, as safety and effectiveness in this age group have not been established.
• Patients with known contraindications, such as narrow-angle glaucoma, kidney disease, or milk allergy, should avoid using this medicine.

Patients with acute conditions should consult with their doctor to determine the safety of using Spiriva in their particular case.

Side effects

Like any medicine, Spiriva can cause side effects that are important to consider during treatment. Some of these effects may be related to the dosage or the individual patients response to the drug.

• The most common side effects include dry mouth and digestive upset, which may manifest as constipation or upset stomach.
• An increased heart rate, or tachycardia, may also occur in some patients in response to the drug.
• Some patients may experience difficulty or pain when urinating, as well as cold-like symptoms such as nasal congestion or sore throat.

If any unusual or severe symptoms occur, you should immediately consult your doctor to assess the need to continue using the drug.